LexiCode

Belkins
Since 1981 LexiCode has provided quality HIM coding and consulting services to healthcare providers nationwide.

Related News

HEALTH TECHNOLOGY

VMWARE ACCELERATES HEALTHCARE PROVIDERS’ ADOPTION OF CLOUD SERVICES

VMware | August 12, 2021

news image

In the wake of the global pandemic, healthcare providers are expanding their telehealth offerings and increasingly opting to host these and other remote patient monitoring and analytics workloads in the cloud. To help ease the transition to the cloud, VMware (NYSE: VMW) today announced GE Healthcare will leverage VMware SD-WAN, now part of VMware SASE, to seamlessly deliver cloud-based services to GE Healthcare customers. “Patient monitoring and diagnostic data a...

Read More

THE PROMISE AND PERIL OF AI IN HEALTHCARE

Managed Healthcare Executive | February 26, 2020

news image

Artificial intelligence (AI) can be used to identify outbreaks such as the coronavirus, which, to date, has resulted in nearly 1,800 reported deaths and more than reported 71,000 infections. In a February 13 webinar, Casey Ross, national technology correspondent for STAT, pointed to efforts by John Brownstein, PhD, chief innovation officer at Boston Children’s Hospital, to use machine learning to review social media posts, reports by physicians, news outlets, and information released by of...

Read More

STANFORD LAUNCHES DATA-DRIVEN MODEL EVALUATING COVID-19 INTERVENTIONS

HealthITAnalytics | April 01, 2020

news image

Researchers at Stanford University have launched an interactive, data-driven model that evaluates possible outcomes of non-pharmaceutical interventions for COVID-19, including social distancing and quarantine. The team aims to help users understand the benefits of delaying the peak of the epidemic and staying below a fixed healthcare capacity. Rather than trying to map the exact dynamics of a certain location, the model shows possible trajectories under different hypothetical scenarios. The mode...

Read More

FDA WARNS AGAINST MALARIA DRUG'S COVID-19 USE OUTSIDE HOSPITALS

FDA | April 24, 2020

news image

The U.S. Food and Drug Administration on Friday cautioned against the use of malaria drug hydroxychloroquine, touted by President Donald Trump, in COVID-19 patients outside of hospitals and clinical trials, citing risks of serious heart rhythm problems. The decades-old drug has been called a “game changer” by Trump in the fight against the novel coronavirus and anecdotal reports that it may provide some benefit have spurred sales of the drug. Within hours of Trump&rsquo...

Read More

HEALTH TECHNOLOGY

VMware | August 12, 2021

news image

VMWARE ACCELERATES HEALTHCARE PROVIDERS’ ADOPTION OF CLOUD SERVICES

In the wake of the global pandemic, healthcare providers are expanding their telehealth offerings and increasingly opting to host these and other remote patient monitoring and analytics workloads in the cloud. To help ease the transition to the cloud, VMware (NYSE: VMW) today announced GE Healthcare will leverage VMware SD-WAN, now part of VMware SASE, to seamlessly deliver cloud-based services to GE Healthcare customers. “Patient monitoring and diagnostic data a...

Read More

Managed Healthcare Executive | February 26, 2020

news image

THE PROMISE AND PERIL OF AI IN HEALTHCARE

Artificial intelligence (AI) can be used to identify outbreaks such as the coronavirus, which, to date, has resulted in nearly 1,800 reported deaths and more than reported 71,000 infections. In a February 13 webinar, Casey Ross, national technology correspondent for STAT, pointed to efforts by John Brownstein, PhD, chief innovation officer at Boston Children’s Hospital, to use machine learning to review social media posts, reports by physicians, news outlets, and information released by of...

Read More

HealthITAnalytics | April 01, 2020

news image

STANFORD LAUNCHES DATA-DRIVEN MODEL EVALUATING COVID-19 INTERVENTIONS

Researchers at Stanford University have launched an interactive, data-driven model that evaluates possible outcomes of non-pharmaceutical interventions for COVID-19, including social distancing and quarantine. The team aims to help users understand the benefits of delaying the peak of the epidemic and staying below a fixed healthcare capacity. Rather than trying to map the exact dynamics of a certain location, the model shows possible trajectories under different hypothetical scenarios. The mode...

Read More

FDA | April 24, 2020

news image

FDA WARNS AGAINST MALARIA DRUG'S COVID-19 USE OUTSIDE HOSPITALS

The U.S. Food and Drug Administration on Friday cautioned against the use of malaria drug hydroxychloroquine, touted by President Donald Trump, in COVID-19 patients outside of hospitals and clinical trials, citing risks of serious heart rhythm problems. The decades-old drug has been called a “game changer” by Trump in the fight against the novel coronavirus and anecdotal reports that it may provide some benefit have spurred sales of the drug. Within hours of Trump&rsquo...

Read More